Press release
Duchenne Muscular Dystrophy Drugs Market Assessment and Key Insights || key Players- Bioleaders Corp, BioMarin Pharmaceutical Inc, Biophytis SAS, Capricor Therapeutics Inc, Catabasis Pharmaceuticals Inc, CRISPR Therapeutics, Cumberland Pharmaceuticals Inc
MRH
This report studies the global Duchenne Muscular Dystrophy Drugs market status and forecast, categorizes the global Duchenne Muscular Dystrophy Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Get Report Sample copy @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1869457
Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness. The disease is caused due to mutations in the dystrophin gene, which result in the lack of production of dystrophin (a protein essential for maintaining healthy muscle function) in individuals. The lack of dystrophin weakens muscle function, causes loss of ambulation, harms the respiratory and cardiac function, and ultimately leads to death.
The main symptoms of this condition appears in childhood and includes delay of motor functions; progressive muscle weakness; muscle contractures in legs; and muscle weakness in arms, neck, and more severely in the lower half of the body. The bones also develop peculiarly, causing skeletal deformities in the patient. Occurrences of pseudo-hypertrophy, cardiomyopathy, and breathing complications are some of the other symptoms of this condition.
The global Duchenne Muscular Dystrophy Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.
The major manufacturers covered in this report
Akashi Therapeutics Inc
Antisense Therapeutics Ltd
Beech Tree Labs Inc
Biogen Inc
Bioleaders Corp
BioMarin Pharmaceutical Inc
Biophytis SAS
Capricor Therapeutics Inc
Catabasis Pharmaceuticals Inc
CRISPR Therapeutics
Cumberland Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Debiopharm International SA
Editas Medicine Inc
Eloxx Pharmaceuticals Inc
F. Hoffmann-La Roche Ltd
FibroGen Inc
Fulcrum Therapeutics Inc
Galapagos NV
Genethon SA
GTx Inc
Santhera Pharmaceuticals Holding AG
Sarepta Therapeutics Inc
SOM Biotech SL
Strykagen Corp
Summit Therapeutics Plc
Taiho Pharmaceutical Co Ltd
Teijin Pharma Ltd
WAVE Life Sciences Ltd
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
Browse Complete Report with TOC @ https://www.marketresearchhub.com/report/global-duchenne-muscular-dystrophy-drugs-market-research-report-2018-report.html
Table of Contents
Global Duchenne Muscular Dystrophy Drugs Market Research Report 2018
1 Duchenne Muscular Dystrophy Drugs Market Overview
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy Drugs
1.2 Duchenne Muscular Dystrophy Drugs Segment by Type (Product Category)
1.2.1 Global Duchenne Muscular Dystrophy Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Duchenne Muscular Dystrophy Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Development & Drug Target
1.2.4 Mechanism of Action (MoA)
1.2.5 Route of Administration (RoA)
1.2.6 Molecule Type
1.3 Global Duchenne Muscular Dystrophy Drugs Segment by Application
1.3.1 Duchenne Muscular Dystrophy Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospitals and Clinics
1.3.3 Medical Laboratories
1.3.4 Others
1.4 Global Duchenne Muscular Dystrophy Drugs Market by Region (2013-2025)
1.4.1 Global Duchenne Muscular Dystrophy Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Duchenne Muscular Dystrophy Drugs (2013-2025)
1.5.1 Global Duchenne Muscular Dystrophy Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Duchenne Muscular Dystrophy Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Duchenne Muscular Dystrophy Drugs Market Competition by Manufacturers
2.1 Global Duchenne Muscular Dystrophy Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Duchenne Muscular Dystrophy Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Duchenne Muscular Dystrophy Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Duchenne Muscular Dystrophy Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Duchenne Muscular Dystrophy Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Duchenne Muscular Dystrophy Drugs Market Competitive Situation and Trends
2.5.1 Duchenne Muscular Dystrophy Drugs Market Concentration Rate
2.5.2 Duchenne Muscular Dystrophy Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Duchenne Muscular Dystrophy Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Duchenne Muscular Dystrophy Drugs Production and Market Share by Region (2013-2018)
3.3 Global Duchenne Muscular Dystrophy Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Duchenne Muscular Dystrophy Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Duchenne Muscular Dystrophy Drugs Consumption by Region (2013-2018)
4.2 North America Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Duchenne Muscular Dystrophy Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Duchenne Muscular Dystrophy Drugs Production and Market Share by Type (2013-2018)
5.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Duchenne Muscular Dystrophy Drugs Price by Type (2013-2018)
5.4 Global Duchenne Muscular Dystrophy Drugs Production Growth by Type (2013-2018)
6 Global Duchenne Muscular Dystrophy Drugs Market Analysis by Application
6.1 Global Duchenne Muscular Dystrophy Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Duchenne Muscular Dystrophy Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
Enquire about this report @ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1869457
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports of different sector and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News at: https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Duchenne Muscular Dystrophy Drugs Market Assessment and Key Insights || key Players- Bioleaders Corp, BioMarin Pharmaceutical Inc, Biophytis SAS, Capricor Therapeutics Inc, Catabasis Pharmaceuticals Inc, CRISPR Therapeutics, Cumberland Pharmaceuticals Inc here
News-ID: 1791568 • Views: …
More Releases from Market Research Hub
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the…
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the…
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section…
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the…
More Releases for Duchenne
Emerging Trends Influencing The Growth Of The Duchenne Muscular Dystrophy (DMD) …
The Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Expected to Be by 2034?
In recent times, the market size for Duchenne Muscular Dystrophy (DMD) therapeutics has seen a significant…
Rising Prevalence Of Chronic Diseases Fuels Growth In The Duchenne Muscular Dyst …
What industry-specific factors are fueling the growth of the duchenne muscular dystrophy market?
The rise in chronic diseases is projected to stimulate the expansion of the Duchenne muscular dystrophy market in the coming years. Chronic diseases are health complications that endure for a minimum of a year. Duchenne muscular dystrophy is instrumental in the increase of chronic diseases as it addresses the unique therapeutic requirements of those suffering from this genetic…
Shaping the Duchenne Muscular Dystrophy (DMD) Therapeutics Market in 2025: Bit B …
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Expected to Be, and What Will Its Growth Rate Be?
The Duchenne muscular dystrophy (DMD) therapeutics market will grow from $11.95 billion in 2024 to $16.45 billion in 2025, at a CAGR of 37.6%. The growth is attributed to the increasing prevalence of Duchenne muscular dystrophy, rising awareness of treatment options, healthcare spending, and government initiatives.
The Duchenne muscular dystrophy (DMD) therapeutics…
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Duchenne Muscular Dystrophy Treatmcent Market
Global Duchenne Muscular Dystrophy Treatmcent Market Set for Robust Growth During Forecast Period
The global Duchenne Muscular Dystrophy Treatment Market is poised to witness significant growth at a high Compound Annual Growth Rate (CAGR) during the forecast period of 2023 to 2030. Duchenne muscular dystrophy (DMD) stands as a genetic disorder marked by progressive muscle degeneration and weakness, with therapeutics aimed at addressing the absence of dystrophin, a crucial protein in…
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market…
